Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth

2 months 2 weeks ago
What drives inflammation-associated tumorigenesis and progression in pancreatic ductal adenocarcinoma (PDAC)? Doublecortin-like kinase 1 (DCLK1) is a central driver of inflammation-associated tumorigenesis, with elevated expression linked to worse clinical outcomes. Two isoforms of DCLK1 possess a unique extracellular domain (ECD). DCLK1 isoform 2 contains two microtubule-binding domains, while isoform 4, lacks the microtubule-binding domains but, plays a pivotal role in tumor progression. We...
Landon L Moore

Clinical utility of randomized controlled trials of regional anesthesia for lower-extremity surgery: a systematic review

2 months 2 weeks ago
BACKGROUND: Regional anesthesia (RA) is central to multimodal analgesia, yet many supporting randomized controlled trials (RCTs) may lack the rigor needed for evidence-based block selection.
Danielle Waller

Rational Design of Metal-Doped Graphitic Materials for Enhanced Lithium-Sulfur Batteries

2 months 2 weeks ago
Atomically dispersed metal atoms within graphitic carbon have shown great potential in enhancing the performance of lithium-sulfur batteries (LSBs), though the fundamental principles to guide their rational design remain to be fully established. Here, we report a combined computational and experimental study demonstrating that a group of metals (Ti, V, Mo, and Nb) incorporated into graphitic carbon have promising catalytic properties due to three factors: strong binding with lithium sulfides,...
Vy Nguyen

Intraoperative Electroencephalogram Alpha Power Associated with Mortality: Reply

2 months 2 weeks ago
No abstract
Rory V Mather

Transfusion of Amustaline/Glutathione Pathogen-reduced Red Blood Cells in Cardiac Surgery: A Randomized Phase 3 Clinical Trial

2 months 2 weeks ago
CONCLUSIONS: The incidence of AKI in recipients of pathogen-reduced red cells was noninferior to conventional red cell transfusion. Treatment-emergent antibodies were uncommon and not clinically significant.
Michael E Sekela

Pagination

  • Page 1
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2025. All rights reserved. Designed By Zymphonies